Temporal Interference for Essential Tremor
Efficacy and Safety of Non-invasive Temporal Interference Stimulation in the Treatment of Essential Tremor: A Pilot Trial
1 other identifier
interventional
10
1 country
1
Brief Summary
This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in essential tremor patients aged 30-70.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2025
CompletedStudy Start
First participant enrolled
June 9, 2025
CompletedFirst Posted
Study publicly available on registry
June 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
July 16, 2025
July 1, 2025
12 months
June 3, 2025
July 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tremor Level Evaluation
Percentage change in per month after stimulation from baseline in The Essential Tremor Rating Assessment Scale(TETRAS) score. The TETRAS score ranges from 0 to 112, including an activities of daily living (ADL) section(0-48 scores) and a performance section(0-64 scores), with higher scores representing more severe tremor and lower scores indicating lower tremor level
Up to 3 months after TI stimulation
Study Arms (1)
Temporal Interference
EXPERIMENTALThe investigators perform temporal interference (TI) stimulation to patients with essential tremor. They observe clinical manifestations before and after stimulation to investigate the efficiency of TI.
Interventions
Researchers apply temporal interference (TI) stimulation to the deep brain nuclei of essential tremor patients.
Eligibility Criteria
You may qualify if:
- Aged 30-70 years old, regardless of gender. Action tremor and postural tremor in both upper limbs, or action tremor and postural tremor in one limb;
- No history of mental diseases;
- Informed consent signed.
You may not qualify if:
- Presence of other neurological diseases affecting the study (such as epilepsy);
- Patients with moderate to severe cognitive impairment (Montreal Cognitive Assessment ≤ 18 points);
- Orthopedic diseases that may affect motor symptoms;
- Patients taking antipsychotic or antidepressant medications;
- Presence of metal implants in the body (such as brain pacemakers or cardiac pacemakers);
- History of electroconvulsive therapy;
- Presence of cardiovascular risk factors, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Liankun_Renlead
Study Sites (1)
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, 100053, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liankun Ren, MD
Xuanwu Hospital, Beijing
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 3, 2025
First Posted
June 11, 2025
Study Start
June 9, 2025
Primary Completion (Estimated)
May 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
July 16, 2025
Record last verified: 2025-07